{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:43:16Z","timestamp":1788817396569,"version":"build-2803163510"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901385"],"award-info":[{"award-number":["81901385"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Although numerous intravenous sedative regimens have been documented, the ideal non-parenteral sedation regimen for magnetic resonance imaging (MRI) has not been determined. This prospective, interventional study aimed to investigate the efficacy and safety of buccal midazolam in combination with intranasal dexmedetomidine in children undergoing MRI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Children between 1 month and 10 years old requiring sedation for MRI examination were recruited to receive buccal midazolam 0.2 mg\u22c5kg<jats:sup>\u20131<\/jats:sup> with intranasal dexmedetomidine 3 \u03bcg\u22c5kg<jats:sup>\u20131<\/jats:sup>. The primary outcome was successful sedation following the administration of the initial sedation regimens and the completion of the MRI examination.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Sedation with dexmedetomidine\u2013midazolam was administered to 530 children. The successful sedation rate was 95.3% (95% confidence interval: 93.5\u201397.1%) with the initial sedation regimens and 97.7% (95% confidence interval: 96.5\u201399%) with a rescue dose of 2 \u03bcg\u22c5kg<jats:sup>\u20131<\/jats:sup> intranasal dexmedetomidine. The median sedation onset time was 10 min, and a significant rising trend was observed in the onset time concerning age (<jats:italic>R<\/jats:italic> = 0.2491, <jats:italic>P<\/jats:italic> &amp;lt; 0.001). The wake-up and discharge times significantly correlated with the duration of the procedure (<jats:italic>R<\/jats:italic> = 0.323, <jats:italic>P<\/jats:italic> &amp;lt; 0.001 vs. <jats:italic>R<\/jats:italic> = 0.325, <jats:italic>P<\/jats:italic> &amp;lt; 0.001). No oxygen deficiency nor medication intervention due to cardiovascular instability was observed in any of the patients. History of a prior failed sedation was considered a statistically significant risk factor for failed sedation in the multivariate logistic regression model [odds ratio = 4.71 (95% confidence interval: 1.24\u201317.9), <jats:italic>P<\/jats:italic> = 0.023].<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In MRI examinations, the addition of buccal midazolam to intranasal dexmedetomidine is associated with a high success rate and a good safety profile. This non-parenteral sedation regimen can be a feasible and convenient option for short-duration MRI in children between 1 month and 10 years.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.889369","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T05:16:23Z","timestamp":1659590183000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Using intranasal dexmedetomidine with buccal midazolam for magnetic resonance imaging sedation in children: A single-arm prospective interventional study"],"prefix":"10.3389","volume":"10","author":[{"given":"Bi Lian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Xiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan Huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna R.","family":"Paquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian M.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing Rong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1213\/ane.0b013e3181981f96","article-title":"Growth rates in pediatric diagnostic imaging and sedation.","volume":"108","author":"Wachtel","year":"2009","journal-title":"Anesthes Anal."},{"key":"B2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1399-6576.2009.02169.x","article-title":"Titrated propofol induction vs. continuous infusion in children undergoing magnetic resonance imaging.","volume":"54","author":"Cho","year":"2010","journal-title":"Acta Anaesthesiol Scand."},{"key":"B3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/pan.13041","article-title":"A retrospective comparison of propofol alone to propofol in combination with dexmedetomidine for pediatric 3T MRI sedation.","volume":"27","author":"Boriosi","year":"2017","journal-title":"Paediatr Anaesth."},{"key":"B4","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1007\/s00247-017-3844-7","article-title":"Experience with the use of propofol for radiologic imaging in infants younger than 6 months of age.","volume":"47","author":"Jenkins","year":"2017","journal-title":"Pediatr Radiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00247-017-3989-4","article-title":"Identification of quality improvement areas in pediatric MRI from analysis of patient safety reports.","volume":"48","author":"Jaimes","year":"2018","journal-title":"Pediatr Radiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/anae.13407","article-title":"A comparison of intranasal dexmedetomidine for sedation in children administered either by atomiser or by drops.","volume":"71","author":"Li","year":"2016","journal-title":"Anaesthesia."},{"key":"B7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/pan.12687","article-title":"Intranasal dexmedetomidine for sedation in children undergoing transthoracic echocardiography study\u2013a prospective observational study.","volume":"25","author":"Li","year":"2015","journal-title":"Paediatr Anaesth."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.872900","article-title":"Efficacy and safety of intranasal dexmedetomidine vs. oral chloral hydrate for sedation in children undergoing computed tomography\/magnetic resonance imaging: a meta-analysis.","volume":"10","author":"Lyu","year":"2022","journal-title":"Front Pediatr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/pan.13498","article-title":"A randomized controlled trial of oral chloral hydrate vs intranasal dexmedetomidine plus buccal midazolam for auditory brainstem response testing in children.","volume":"28","author":"Li","year":"2018","journal-title":"Paediatr Anaesthes."},{"key":"B10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s40272-015-0145-1","article-title":"Comparison of two different intranasal doses of dexmedetomidine in children for magnetic resonance imaging sedation.","volume":"17","author":"Tug","year":"2015","journal-title":"Paediatr Drugs."},{"key":"B11","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/pan.13202","article-title":"Combination of intranasal dexmedetomidine and oral midazolam as sedation for pediatric MRI.","volume":"27","author":"Cozzi","year":"2017","journal-title":"Paediatr Anaesth."},{"key":"B12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/PEC.0000000000001199","article-title":"The use of intranasal dexmedetomidine and midazolam for sedated magnetic resonance imaging in children: a report from the pediatric sedation research consortium.","volume":"36","author":"Sulton","year":"2020","journal-title":"Pediatr Emerg Care."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-021-01196-0","article-title":"Intranasal dexmedetomidine and intranasal ketamine association allows shorter induction time for pediatric sedation compared to intranasal dexmedetomidine and oral midazolam.","volume":"48","author":"Cossovel","year":"2022","journal-title":"Ital J Pediatr."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-017-0454-8","article-title":"Pediatric premedication: a double-blind randomized trial of dexmedetomidine or ketamine alone versus a combination of dexmedetomidine and ketamine.","volume":"17","author":"Qiao","year":"2017","journal-title":"BMC Anesthesiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1542\/hpeds.2018-0162","article-title":"Safety and efficacy of buccal dexmedetomidine for MRI sedation in school-aged children.","volume":"9","author":"Boriosi","year":"2019","journal-title":"Hosp Pediatr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2165\/11209320-000000000-00000","article-title":"Oromucosal midazolam: a review of its use in pediatric patients with prolonged acute convulsive seizures.","volume":"14","author":"Garnock-Jones","year":"2012","journal-title":"Paediatr Drugs."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1007\/s10803-019-04095-w","article-title":"A comparison of intranasal dexmedetomidine and dexmedetomidine plus buccal midazolam for non-painful procedural sedation in children with autism.","volume":"49","author":"Li","year":"2019","journal-title":"J Autism Dev Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/jcph.1751","article-title":"Absolute bioavailability of microdosed midazolam after buccal administration is dependent on buccal exposure time.","volume":"61","author":"Grass","year":"2021","journal-title":"J Clin Pharmacol."},{"key":"B19","author":"Ralston","year":"2006","journal-title":"American Heart Association, American Academy of Pediatrics. Pals Course Guide."},{"key":"B20","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1542\/peds.2012-0055I","article-title":"Standard 6: age groups for pediatric trials.","volume":"129","author":"Williams","year":"2012","journal-title":"Pediatrics."},{"key":"B21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/pan.14307","article-title":"Safety and effectiveness of intranasal dexmedetomidine together with midazolam for sedation in neonatal MRI.","volume":"32","author":"Inserra","year":"2022","journal-title":"Paediatr Anaesth."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1097\/SCS.0000000000006657","article-title":"Observation of the sedative effect of dexmedetomidine combined with midazolam nasal drops before a pediatric craniocerebral MRI.","volume":"31","author":"Wu","year":"2020","journal-title":"J Craniofac Surg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/pan.12408","article-title":"Comparison of propofol and dexmedetomedine techniques in children undergoing magnetic resonance imaging.","volume":"24","author":"Wu","year":"2014","journal-title":"Paediatr Anaesthes."},{"key":"B24","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1460-9592.2009.03023.x","article-title":"Propofol vs pentobarbital for sedation of children undergoing magnetic resonance imaging: results from the pediatric sedation research consortium.","volume":"19","author":"Mallory","year":"2009","journal-title":"Paediatr Anaesthes."},{"key":"B25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/pan.13526","article-title":"Analysis of 17 948 pediatric patients undergoing procedural sedation with a combination of intranasal dexmedetomidine and ketamine.","volume":"29","author":"Yang","year":"2019","journal-title":"Paediatr Anaesth."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.2147\/DDDT.S269765","article-title":"Ketamine enhances intranasal dexmedetomidine-induced sedation in children: a randomized, double-blind trial.","volume":"14","author":"Qian","year":"2020","journal-title":"Drug Des Devel Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00247-014-3091-0","article-title":"Chloral hydrate in pediatric magnetic resonance imaging: evaluation of a 10-year sedation experience administered by radiologists.","volume":"45","author":"Delgado","year":"2015","journal-title":"Pediatr Radiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.pharma.2018.03.002","article-title":"Oral pentobarbital suspension for children sedation during MR imaging.","volume":"76","author":"Schlatter","year":"2018","journal-title":"Ann Pharm Fr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1460-9592.2005.01820.x","article-title":"Oral sedation with midazolam and diphenhydramine compared with midazolam alone in children undergoing magnetic resonance imaging.","volume":"16","author":"Cengiz","year":"2006","journal-title":"Paediatr Anaesth."},{"key":"B30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.12701\/yujm.2020.00171","article-title":"Drug selection for sedation and general anesthesia in children undergoing ambulatory magnetic resonance imaging.","volume":"37","author":"Jung","year":"2020","journal-title":"Yeungnam Univ J Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/pan.13529","article-title":"Sedation effects of intranasal dexmedetomidine combined with ketamine and risk factors for sedation failure in young children during transthoracic echocardiography.","volume":"29","author":"Liu","year":"2019","journal-title":"Paediatr Anaesth."},{"key":"B32","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1467-2995.2010.00565.x","article-title":"Midazolam enhances the analgesic properties of dexmedetomidine in the rat.","volume":"37","author":"Boehm","year":"2010","journal-title":"Vet Anaesth Analg."},{"key":"B33","first-page":"347","article-title":"Quantification of pharmacodynamic interactions between dexmedetomidine and midazolam in the rat.","volume":"294","author":"Bol","year":"2000","journal-title":"J Pharmacol Exp Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/pan.13400","article-title":"Low-Dose Dexmedetomidine as an Adjuvant to Propofol Infusion for Children in Mri: A Double-Cohort Study.","volume":"28","author":"Nagoshi","year":"2018","journal-title":"Paediatric anaesthesia"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1213\/ane.0b013e31818874ee","article-title":"A comparison of dexmedetomidine-midazolam with propofol for maintenance of anesthesia in children undergoing magnetic resonance imaging.","volume":"107","author":"Heard","year":"2008","journal-title":"Anesth Analg."},{"key":"B36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.joms.2018.07.002","article-title":"Dexmedetomidine and midazolam sedation reduces unexpected patient movement during dental surgery compared with propofol and midazolam sedation.","volume":"77","author":"Togawa","year":"2019","journal-title":"J Oral Maxillofac Surg."},{"key":"B37","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1542\/peds.2010-0616","article-title":"Intranasal medication delivery for children: a brief review and update.","volume":"126","author":"Wolfe","year":"2010","journal-title":"Pediatrics."},{"key":"B38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1148\/radiol.2371041415","article-title":"Adverse cardiovascular and respiratory events during sedation of pediatric patients for imaging examinations.","volume":"237","author":"Sanborn","year":"2005","journal-title":"Radiology."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1053\/j.jvca.2019.12.045","article-title":"A comparison of intranasal dexmedetomidine and dexmedetomidine-ketamine combination sedation for transthoracic echocardiography in pediatric patients with congenital heart disease: a randomized controlled trial.","volume":"34","author":"Sun","year":"2020","journal-title":"J Cardiothorac Vasc Anesth."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.889369\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T05:16:29Z","timestamp":1659590189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.889369\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":39,"alternative-id":["10.3389\/fped.2022.889369"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.889369","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,4]]},"article-number":"889369"}}